Pulsatile flow: A critical modulator of the natural history of atherosclerosis

Yiannis S. Chatzizisis, George D. Giannoglou

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Atherosclerosis is a systemic process with multi-focal distribution which progresses or regresses in an entirely independent manner within each patient. The low and oscillatory shear stress along with the geometrical particularities of the coronaries modulate an atherogenic microenvironment in susceptible to atherosclerosis regions and determine the disease's rate of progression. However, the atherogenic effect of flow pulsation remains ambiguous. Since the pulsatile nature of the blood constitutes the major generator of the oscillatory shear stress, one could hypothesize that this physiological process might exert a synergistic effect to low SS by facilitating the lesion progression. The heart rate determines directly the frequency of flow pulsation; therefore, its reduction could potentially decelerate the progression of atherosclerosis by alleviating the local atherogenic hemodynamic environment. This perspective might constitute an insight into the beneficial role of heart rate lowering agents with most significant representative the β-blockers, which have been proved quite efficient anti-atherosclerotic drugs.

Original languageEnglish (US)
Pages (from-to)338-340
Number of pages3
JournalMedical Hypotheses
Volume67
Issue number2
DOIs
StatePublished - Jun 12 2006

Fingerprint

Pulsatile Flow
Atherosclerosis
Heart Rate
Physiological Phenomena
Disease Progression
Hemodynamics
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Pulsatile flow : A critical modulator of the natural history of atherosclerosis. / Chatzizisis, Yiannis S.; Giannoglou, George D.

In: Medical Hypotheses, Vol. 67, No. 2, 12.06.2006, p. 338-340.

Research output: Contribution to journalArticle

@article{f4f49740b0014813b2cbe85c862354b3,
title = "Pulsatile flow: A critical modulator of the natural history of atherosclerosis",
abstract = "Atherosclerosis is a systemic process with multi-focal distribution which progresses or regresses in an entirely independent manner within each patient. The low and oscillatory shear stress along with the geometrical particularities of the coronaries modulate an atherogenic microenvironment in susceptible to atherosclerosis regions and determine the disease's rate of progression. However, the atherogenic effect of flow pulsation remains ambiguous. Since the pulsatile nature of the blood constitutes the major generator of the oscillatory shear stress, one could hypothesize that this physiological process might exert a synergistic effect to low SS by facilitating the lesion progression. The heart rate determines directly the frequency of flow pulsation; therefore, its reduction could potentially decelerate the progression of atherosclerosis by alleviating the local atherogenic hemodynamic environment. This perspective might constitute an insight into the beneficial role of heart rate lowering agents with most significant representative the β-blockers, which have been proved quite efficient anti-atherosclerotic drugs.",
author = "Chatzizisis, {Yiannis S.} and Giannoglou, {George D.}",
year = "2006",
month = "6",
day = "12",
doi = "10.1016/j.mehy.2006.02.005",
language = "English (US)",
volume = "67",
pages = "338--340",
journal = "Medical Hypotheses",
issn = "0306-9877",
publisher = "Churchill Livingstone",
number = "2",

}

TY - JOUR

T1 - Pulsatile flow

T2 - A critical modulator of the natural history of atherosclerosis

AU - Chatzizisis, Yiannis S.

AU - Giannoglou, George D.

PY - 2006/6/12

Y1 - 2006/6/12

N2 - Atherosclerosis is a systemic process with multi-focal distribution which progresses or regresses in an entirely independent manner within each patient. The low and oscillatory shear stress along with the geometrical particularities of the coronaries modulate an atherogenic microenvironment in susceptible to atherosclerosis regions and determine the disease's rate of progression. However, the atherogenic effect of flow pulsation remains ambiguous. Since the pulsatile nature of the blood constitutes the major generator of the oscillatory shear stress, one could hypothesize that this physiological process might exert a synergistic effect to low SS by facilitating the lesion progression. The heart rate determines directly the frequency of flow pulsation; therefore, its reduction could potentially decelerate the progression of atherosclerosis by alleviating the local atherogenic hemodynamic environment. This perspective might constitute an insight into the beneficial role of heart rate lowering agents with most significant representative the β-blockers, which have been proved quite efficient anti-atherosclerotic drugs.

AB - Atherosclerosis is a systemic process with multi-focal distribution which progresses or regresses in an entirely independent manner within each patient. The low and oscillatory shear stress along with the geometrical particularities of the coronaries modulate an atherogenic microenvironment in susceptible to atherosclerosis regions and determine the disease's rate of progression. However, the atherogenic effect of flow pulsation remains ambiguous. Since the pulsatile nature of the blood constitutes the major generator of the oscillatory shear stress, one could hypothesize that this physiological process might exert a synergistic effect to low SS by facilitating the lesion progression. The heart rate determines directly the frequency of flow pulsation; therefore, its reduction could potentially decelerate the progression of atherosclerosis by alleviating the local atherogenic hemodynamic environment. This perspective might constitute an insight into the beneficial role of heart rate lowering agents with most significant representative the β-blockers, which have been proved quite efficient anti-atherosclerotic drugs.

UR - http://www.scopus.com/inward/record.url?scp=33744803482&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33744803482&partnerID=8YFLogxK

U2 - 10.1016/j.mehy.2006.02.005

DO - 10.1016/j.mehy.2006.02.005

M3 - Article

C2 - 16546326

AN - SCOPUS:33744803482

VL - 67

SP - 338

EP - 340

JO - Medical Hypotheses

JF - Medical Hypotheses

SN - 0306-9877

IS - 2

ER -